Skip to main content
low healthVERIFIED◈ 5 SOURCES

FDA adds rare vision-loss warning to popular GLP-1 weight loss drugs

Verified: 10 outlets in 7 countries have reported this story since Nov 9, 2 of them from the United States.

📍 Washington, US·🕐 1d ago·10 outlets

WASHINGTON (AP) – Popular weight loss drugs, including Ozempic and Wegovy, will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, United States health regulators announced on Monday. The Food and Drug Administration said the risk will be added to the labeling of all GLP-1 drugs, the blockbuster medications used to treat obesity, diabetes and several other medical conditions. The class includes a dozen injectable or pill-based drugs, including widely used brands like Zepbound and Mounjaro.

How sure are we

✓ Verified · 10 outlets

Two or more outlets reported this story and its reliability score reached 65%, so WorldPulse marks it verified. That means more than one outlet says so, not that it is proven true.

How we count · Check a link someone shared

Who reported it

The story so far · 12 reports · · 7 countries✓ Verified Nov 9, 9:58 PM UTC

2 outlets from the United States, where the story is: Ars Technica, STAT News · how we count

  1. Nov 9, 4:19 PM UTCFirst report
    STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye conditionstatnews.com ↗
  2. Nov 9, 4:47 PM UTC+28 min
    FDA requires vision-loss warning on Novo Nordisk and Eli Lilly GLP-1 drugsinvesting.com ↗
  3. Nov 9, 9:58 PM UTC+6 h· you’re reading this
    FDA adds rare vision-loss warning to popular GLP-1 weight loss drugsjamaica-gleaner.com ↗
  4. Nov 10, 8:21 PM UTC+28 h
    Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindnessbbc.co.uk ↗
  5. Nov 10, 8:42 PM UTC+28 h
    FDA warns of rare eye condition causing blindness from GLP-1 weight loss medicationstheguardian.com ↗
  6. Nov 10, 8:44 PM UTC+28 h
    FDA warns of rare eye condition causing blindness from GLP-1 weight loss medicationstheguardian.com (again) ↗
  7. Nov 11, 9:19 AM UTC+41 h
    Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindnesskbc.co.ke ↗
Location
Verification Log1
cross checkconfirmed90%

[Claude] All three other reports cover the same FDA announcement of a vision-loss warning on GLP-1 drugs, with no conflicting facts.

17h ago
Powered by WorldPulse Verification Engine
Discussion (0)

Sign in to join the discussion

No discussion yet — be the first to add context.

Reliability
96%

Very high · How we score this

Risk Score
low risk